These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 9786306)

  • 1. Cardiovascular effects of antidepressant drugs: updated.
    Glassman AH
    J Clin Psychiatry; 1998; 59 Suppl 15():13-8. PubMed ID: 9786306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of antidepressant drugs in patients with heart disease.
    Glassman AH; Rodriguez AI; Shapiro PA
    J Clin Psychiatry; 1998; 59 Suppl 10():16-21. PubMed ID: 9720478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of patients with depression associated with anxiety symptoms.
    Nutt D
    J Clin Psychiatry; 1997; 58 Suppl 8():11-6. PubMed ID: 9236730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels and cardiovascular effects of tricyclic antidepressants and selective serotonin reuptake inhibitors in depressed patients.
    Rodriguez de la Torre B; Dreher J; Malevany I; Bagli M; Kolbinger M; Omran H; Lüderitz B; Rao ML
    Ther Drug Monit; 2001 Aug; 23(4):435-40. PubMed ID: 11477329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SSRIS versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability.
    Anderson IM
    Depress Anxiety; 1998; 7 Suppl 1():11-7. PubMed ID: 9597346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluvoxamine and tricyclic antidepressants (TCAs): how do the TCAs compare as "new" drugs with established fluvoxamine?
    Ashford JJ
    Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 4():27-31. PubMed ID: 7622820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective serotonin reuptake inhibitors and tricyclic antidepressants in combination. Interactions and therapeutic uses.
    Taylor D
    Br J Psychiatry; 1995 Nov; 167(5):575-80. PubMed ID: 8564311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depression: treating the patient with comorbid cardiac disease.
    Roose SP; Devanand D; Suthers K
    Geriatrics; 1999 Feb; 54(2):20-1, 25-6, 29-31 passim. PubMed ID: 10024871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depression, anxiety, and the cardiovascular system: the psychiatrist's perspective.
    Roose SP
    J Clin Psychiatry; 2001; 62 Suppl 8():19-22; discussion 23. PubMed ID: 12108817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implications of the pharmacology of serotonin reuptake inhibitors.
    Warrington SJ
    Int Clin Psychopharmacol; 1992 Oct; 7 Suppl 2():13-9. PubMed ID: 1484174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.
    Anderson IM
    J Affect Disord; 2000 Apr; 58(1):19-36. PubMed ID: 10760555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of moclobemide in comparison with placebo, tricyclic antidepressants, and selective serotonin reuptake inhibitors in elderly depressed patients: a clinical overview.
    Amrein R; Stabl M; Henauer S; Affolter E; Jonkanski I
    Can J Psychiatry; 1997 Dec; 42(10):1043-50. PubMed ID: 9469236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of depression in patients with heart disease.
    Roose SP
    Biol Psychiatry; 2003 Aug; 54(3):262-8. PubMed ID: 12893102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of severe depression with the selective serotonin reuptake inhibitors.
    Schatzberg AF
    Depress Anxiety; 1996-1997; 4(4):182-9. PubMed ID: 9166650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of cardiovascular effects of fluoxetine, a selective serotonin reuptake inhibitor, compared to tricyclic antidepressants.
    Pacher P; Ungvari Z; Kecskemeti V; Furst S
    Curr Med Chem; 1998 Oct; 5(5):381-90. PubMed ID: 9756980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective serotonin reuptake inhibitors versus tricyclic antidepressants in young patients: a meta-analysis of efficacy and acceptability.
    Qin B; Zhang Y; Zhou X; Cheng P; Liu Y; Chen J; Fu Y; Luo Q; Xie P
    Clin Ther; 2014 Jul; 36(7):1087-1095.e4. PubMed ID: 24998011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developments in the drug treatment of panic disorder: what is the place of the selective serotonin reuptake inhibitors?
    Westenberg HG
    J Affect Disord; 1996 Sep; 40(1-2):85-93. PubMed ID: 8882918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants.
    Perry PJ
    J Affect Disord; 1996 Jun; 39(1):1-6. PubMed ID: 8835647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contemporary management of depression.
    Andrews JM; Nemeroff CB
    Am J Med; 1994 Dec; 97(6A):24S-32S. PubMed ID: 7992823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of selective serotonin reuptake inhibitors versus tricyclic antidepressants on cerebrovascular events: a nationwide population-based cohort study.
    Lee YC; Lin CH; Lin MS; Lin JW; Chang CH; Lai MS
    J Clin Psychopharmacol; 2013 Dec; 33(6):782-9. PubMed ID: 24091857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.